Mr. Marc Edwards reports

KANE BIOTECH TO RELEASE SECOND QUARTER 2023 FINANCIAL RESULTS ON AUG 29, 2023 - CONFERENCE CALL TO FOLLOW

Kane Biotech Inc. will release its second quarter 2023 financial results after market close on Tuesday, Aug. 29, 2023.

Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.

Participants must register for the call on-line to receive the dial-in numbers and unique PIN to access the call seamlessly. It is recommended that you join 10 minutes before the event, though you may preregister at any time. A webcast of the call will be available on the company's website in the investor section.

About Kane Biotech Inc.

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property (80 patents and patents pending, trade secrets, and trademarks) and products developed by the company's own biofilm research expertise and acquired from leading research institutions. StrixNB, DispersinB, Aledex, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm are trademarks of Kane Biotech.

We seek Safe Harbor.